141 related articles for article (PubMed ID: 24880652)
1. Malignant transformation of endometriosis and its clinical significance.
Nezhat F; Apostol R; Mahmoud M; el Daouk M
Fertil Steril; 2014 Aug; 102(2):342-4. PubMed ID: 24880652
[No Abstract] [Full Text] [Related]
2. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.
Mandai M; Yamaguchi K; Matsumura N; Baba T; Konishi I
Int J Clin Oncol; 2009 Oct; 14(5):383-91. PubMed ID: 19856044
[TBL] [Abstract][Full Text] [Related]
3. Cancer Implications for Patients with Endometriosis.
Wilbur MA; Shih IM; Segars JH; Fader AN
Semin Reprod Med; 2017 Jan; 35(1):110-116. PubMed ID: 28049216
[TBL] [Abstract][Full Text] [Related]
4. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.
Munksgaard PS; Blaakaer J
Gynecol Oncol; 2012 Jan; 124(1):164-9. PubMed ID: 22032835
[TBL] [Abstract][Full Text] [Related]
5. CDC42-positive macrophages may prevent malignant transformation of ovarian endometriosis.
Canet B; Pons C; Espinosa I; Prat J
Hum Pathol; 2012 May; 43(5):720-5. PubMed ID: 21944080
[TBL] [Abstract][Full Text] [Related]
6. Malignant transformation of pelvic endometriosis: MR imaging findings and pathologic correlation.
Takeuchi M; Matsuzaki K; Uehara H; Nishitani H
Radiographics; 2006; 26(2):407-17. PubMed ID: 16549606
[TBL] [Abstract][Full Text] [Related]
7. Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst.
Noack F; Schmidt H; Buchweitz O; Malik E; Horny HP
Anticancer Res; 2004; 24(1):151-4. PubMed ID: 15015590
[TBL] [Abstract][Full Text] [Related]
8. The relationship of endometriosis and ovarian malignancy: a review.
Nezhat F; Datta MS; Hanson V; Pejovic T; Nezhat C; Nezhat C
Fertil Steril; 2008 Nov; 90(5):1559-70. PubMed ID: 18993168
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis.
Kobayashi H
Int J Clin Oncol; 2009 Oct; 14(5):378-82. PubMed ID: 19856043
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer in endometriosis.
Konishi I
Int J Clin Oncol; 2009 Oct; 14(5):377. PubMed ID: 19856042
[No Abstract] [Full Text] [Related]
11. Malignant transformation of endometriosis: application of laser microdissection for analysis of genetic alterations according to pathological changes.
Sekizawa A; Amemiya S; Otsuka J; Saito H; Farina A; Okai T; Tachikawa T
Med Electron Microsc; 2004 Jun; 37(2):97-100. PubMed ID: 15221651
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 16 expression changes in association with ovarian malignant transformation.
Yellapa A; Bitterman P; Sharma S; Guirguis AS; Bahr JM; Basu S; Abramowicz JS; Barua A
Am J Obstet Gynecol; 2014 Mar; 210(3):272.e1-10. PubMed ID: 24380743
[TBL] [Abstract][Full Text] [Related]
13. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis.
Ali-Fehmi R; Khalifeh I; Bandyopadhyay S; Lawrence WD; Silva E; Liao D; Sarkar FH; Munkarah AR
Int J Gynecol Pathol; 2006 Jul; 25(3):223-9. PubMed ID: 16810057
[TBL] [Abstract][Full Text] [Related]
14. [bcl-2 and p53 protein expressions in the malignant transformation of ovarian endometriosis].
Qian J; Shi Y
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):403-5. PubMed ID: 11810773
[TBL] [Abstract][Full Text] [Related]
15. [Endometriosis-associated ovarian cancers: pathogenesis and consequences on daily practice].
Borghese B; Santulli P; Vaiman D; Alexandre J; Goldwasser F; Chapron C
J Gynecol Obstet Biol Reprod (Paris); 2013 Jun; 42(4):325-33. PubMed ID: 23578493
[TBL] [Abstract][Full Text] [Related]
16. MUC1 in endometriosis and ovarian cancer.
Vlad AM; Diaconu I; Gantt KR
Immunol Res; 2006; 36(1-3):229-36. PubMed ID: 17337783
[TBL] [Abstract][Full Text] [Related]
17. Methylation status of the gene promoter of cyclin-dependent kinase inhibitor 2A (CDKN2A) in ovarian cancer.
Abou-Zeid AA; Azzam AZ; Kamel NA
Scand J Clin Lab Invest; 2011 Nov; 71(7):542-7. PubMed ID: 21728901
[TBL] [Abstract][Full Text] [Related]
18. Differentiation and proliferation related proteins in the epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition.
McCluggage WG
Histopathology; 2004 Sep; 45(3):298-9. PubMed ID: 15330810
[No Abstract] [Full Text] [Related]
19. K-ras mutation may promote carcinogenesis of endometriosis leading to ovarian clear cell carcinoma.
Otsuka J; Okuda T; Sekizawa A; Amemiya S; Saito H; Okai T; Kushima M; Tachikawa T
Med Electron Microsc; 2004 Sep; 37(3):188-92. PubMed ID: 15449112
[TBL] [Abstract][Full Text] [Related]
20. Potential scenarios leading to ovarian cancer arising from endometriosis.
Kobayashi H
Redox Rep; 2016 May; 21(3):119-26. PubMed ID: 26317761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
